Menu

MagnetTx Oncology Solutions Ltd. Announces Strategic Alliance with Akesis Inc.

MagnetTx Oncology Solutions Ltd.

Innovative Partnership to Deliver Advanced Radiation Therapy Solutions.

 

Edmonton, AlbertaTheNewswire - September 27, 2024 - MagnetTx Oncology Solutions Ltd. (“MagnetTx”), the designer, manufacturer, and marketer of the cutting-edge Aurora-RT LinacMR system, is pleased to announce a strategic alliance with Akesis Inc. (“Akesis”), a renowned radiotherapy company based in Concord, California, providing the Gemini360RT adaptive radiation therapy turnkey solution and the Galaxy line of dedicated stereotactic radiosurgery treatment units.

 

Under the strategic alliance, MagnetTx and Akesis will co-market their combined product line. The combined MagnetTx and Akesis commercial team brings decades of expertise in launching a full spectrum of radiotherapy and radiosurgery products, providing healthcare providers with a comprehensive suite of adaptive delivery hardware and software solutions.

 

“Our partnership is rooted in a shared vision to enhance patient care and improve clinic efficiency and treatment outcomes,” says Michael Cogswell, MagnetTx President and CEO.

 

Stay tuned for more updates as we work together to redefine the future of radiation therapy.

  

About MagnetTx

MagnetTx Oncology Solutions Ltd. is a Canadian-based company that develops global pioneering technology. We’ve combined a linear accelerator (Linac), with real-time (concurrent) magnetic resonance imaging (MRI) to deliver radiotherapy to cancer patients. Our goal is to substantially reduce radiation treatment margins and improve cancer patient outcomes with fewer adverse side effects. Our first device is the groundbreaking Aurora-RT™.

 

For media inquiries, please contact:

Jessica Cogswell: Jessica.cogswell@magnettx.com

MagnetTx.com

 

Copyright (c) 2024 TheNewswire - All rights reserved.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.